Susceptibilities of several drug-resistant varicella-zoster virus (VZV) strains to bicyclic pyrimidine nucleoside analogues (BCNAs)

被引：0
|
作者：
Andrei, G
Sienaert, R
Naesens, L
De Clercq, E
McGuigan, C
Balzarini, J
Snoeck, R
机构：
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Wales Coll Cardiff, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
来源：
ANTIVIRAL RESEARCH | 2002年 / 53卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
81
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [21] Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer
    Degreve, B
    Andrei, G
    Izquierdo, M
    Piette, J
    Morin, K
    Knaus, EE
    Wiebe, LI
    Basrah, I
    Walker, RT
    DeClercq, E
    Balzarini, J
    GENE THERAPY, 1997, 4 (10) : 1107 - 1114
  • [22] Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus
    McGuigan, Christopher
    Pathirana, Ranjith N.
    Migliore, Marco
    Adak, Rina
    Luoni, Giovanna
    Jones, Arwyn T.
    Diez-Torrubia, Alberto
    Camarasa, Maria-Jose
    Velazquez, Sonsoles
    Henson, Geoffrey
    Verbeken, Erik
    Sienaert, Rebecca
    Naesens, Lieve
    Snoeck, Robert
    Andrei, Graciela
    Balzarini, Jan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1316 - 1330
  • [23] SAR of monosubstituted phenyl furano pyrimidine as potent and selective anti Varicella-Zoster Virus (VZV) compounds
    Migliore, M
    Bidet, O
    McGuigan, C
    Snoeck, R
    Andrei, G
    De Clercq, E
    Balzarini, J
    ANTIVIRAL RESEARCH, 2006, 70 (01) : A67 - A67
  • [24] GENOTYPING OF VARICELLA-ZOSTER VIRUS (VZV) WILD-TYPE STRAINS ISOLATED IN THE CZECH REPUBLIC
    Bostikova, Vanda
    Salavec, Miloslav
    Smetana, Jan
    Chlibek, Roman
    Kosina, Pavel
    Prasil, Petr
    Plisek, Stanislav
    Splino, Miroslav
    Bostik, Pavel
    BIOMEDICAL PAPERS-OLOMOUC, 2011, 155 (04): : 379 - 384
  • [25] Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against Varicella Zoster Virus
    McGuigan, Christopher
    Bidet, Olivier
    Derudas, Marco
    Andrei, Graciela
    Snoeck, Robert
    Balzarini, Jan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (08) : 3025 - 3027
  • [26] DRUG SUSCEPTIBILITIES OF ISOLATES OF VARICELLA-ZOSTER VIRUS IN A CLINICAL-STUDY OF ORAL BROVAVIR
    MACHIDA, H
    NISHITANI, M
    MICROBIOLOGY AND IMMUNOLOGY, 1990, 34 (04) : 407 - 411
  • [27] Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro
    Sasivimolphan, Pattaraporn
    Lipipun, Vimolmas
    Likhitwitayawuid, Kittisak
    Takemoto, Masaya
    Pramyothin, Pornpen
    Hattori, Masao
    Shiraki, Kimiyasu
    ANTIVIRAL RESEARCH, 2009, 84 (01) : 95 - 97
  • [28] ISOLATION OF DRUG-RESISTANT MUTANTS OF VARICELLA-ZOSTER VIRUS - CROSS RESISTANCE OF ACYCLOVIR RESISTANT MUTANTS WITH PHOSPHONOACETIC ACID AND BROMODEOXYURIDINE
    SHIRAKI, K
    OGINO, T
    YAMANISHI, K
    TAKAHASHI, M
    BIKEN JOURNAL, 1983, 26 (01) : 17 - 23
  • [29] Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus
    Ashida, N
    Watanabe, Y
    Miura, S
    Kano, F
    Sakata, S
    Yamaguchi, T
    Suzutani, T
    Machida, H
    ANTIVIRAL RESEARCH, 1997, 35 (03) : 167 - 175
  • [30] INFECTION OF GUINEA-PIG EMBRYO CELLS WITH WILD AND VACCINE STRAINS OF VARICELLA-ZOSTER VIRUS (VZV)
    EDMOND, BJ
    GROSE, C
    BRUNELL, PA
    PEDIATRIC RESEARCH, 1980, 14 (04) : 557 - 557
12345